Ramakrishnan Gopalakrishnan

4PUBLICATIONS
2CO-AUTHORS
Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 03, 2020
Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma.

Ramakrishnan Gopalakrishnan, Hittu Matta, Sunju Choi

|Feb 13, 2020
A Fast and Sensitive Luciferase-based Assay for Antibody Engineering and Design of Chimeric Antigen Receptors.

Venkatesh Natarajan, Ramakrishnan Gopalakrishnan, Hittu Matta

|Feb 15, 2019
A novel luciferase-based assay for the detection of Chimeric Antigen Receptors.

Ramakrishnan Gopalakrishnan, Hittu Matta, Sunju Choi

|Jan 11, 2018
Development and characterization of a novel luciferase based cytotoxicity assay.

Hittu Matta, Ramakrishnan Gopalakrishnan, Sunju Choi

Pageof 1